Contribution of amino acids in protective solutions to postischemic functional recovery of canine kidneys.
Amino acids are known to increase glomerular filtration rate (GFR). There is also an early resumption of filtration following 2-h renal ischemic stress under protection by histidine-buffered histidine-tryptophan-ketoglutarate solution (HTK), possibly due in part to an amino acid effect. Hence, we have examined the possibility of further enhancing the postischemic GFR by adding 32 (ASP I; 4 mM Mg2+) or 36 (ASP II; 6 mM Mg2+) mM L-aspartate (asp) or 32 mM DL-aspartate (ASP III) to the HTK solution in place of chloride. After infusion of 500 ml 5% glucose, canine kidneys were protected by an 8-min perfusion with HTK (n = 5), ASP I (n = 4), ASP II (n = 5) or ASP III-solution (n = 3). The subsequent ischemia lasted for 2 h at 27-31 degrees C. During reperfusion, both GFR and filtration fraction (FF) were higher in kidneys protected by L-aspartate-containing solutions. ASP III showed no improvement against HTK. An additional preischemic intra-aortal application of HTK or ASP I solution just above the exit of the renal arteries prior to the intrinsic protective perfusion further raised the postischemic GFR. The present results suggest that L-aspartate but also histidine may have favorable amino acid effects in renal protective solutions in addition to known positive effects of histidine.
Kehrer
G
G
Department of Physiology and Pathophysiology, University of Göttingen, FRG.
Blech
M
M
Kallerhoff
M
M
Langheinrich
M
M
Bretschneider
H J
HJ
D000818:Animals; D001011:Aorta; D001224:Aspartic Acid / Q000008:administration & dosage / Q000494:pharmacology*; D004231:Diuresis / Q000187:drug effects; D004285:Dogs; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects*; D005947:Glucose / Q000008:administration & dosage; D006639:Histidine / Q000494:pharmacology*; D007511:Ischemia / Q000503:physiopathology*; D007668:Kidney / Q000098:blood supply* / Q000187:drug effects / Q000503:physiopathology; D007677:Kidney Function Tests; D008297:Male; D008353:Mannitol / Q000008:administration & dosage; D010101:Oxygen Consumption / Q000187:drug effects; D010477:Perfusion; D011189:Potassium Chloride / Q000008:administration & dosage; D011343:Procaine / Q000008:administration & dosage; D012039:Regional Blood Flow / Q000187:drug effects; D015424:Reperfusion
C039984:Bretschneider cardioplegic solution; D001224:Aspartic Acid; D008353:Mannitol; D006639:Histidine; D011343:Procaine; D011189:Potassium Chloride; D005947:Glucose